Increment of antimycobaterial activity on lichexanthone derivatives

Medicinal Chemistry

Volumn 9, Issue 7, 2013, Pages 904-910

  Micheletti, Ana Camila ^a   Honda, Neli Kika ^a   Pavan, Fernando R ^b   Leite, Clarice Q F ^b   De Fatima Cepa Matos, Maria ^a   Perdomo, Renata Trentin ^a   Bogo, Danielle ^a   Alcantara, Glaucia Braz ^a   Beatriz, Adilson ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chemometrics; Lichen; Structural modifications; Tuberculosis; Xanthone

Indexed keywords

1 HYDROXY 3 METHOXY 8, 6',6' TRIMETHYL 4',5' DIHYDROPYRANE(2',3':5,6) 9H XANTHEN 9 ONE; 1 HYDROXY 8 METHYL 3,6 BIS(3 PIPERIDIN 1 YLPROPOXY) 9H XANTHEN 9 ONE; 1 HYDROXY 8 METHYL 3,6 BIS(4 PIPERIDIN 1 YLBUTOXY) 9H XANTHEN 9 ONE; 1 HYDROXY 8 METHYL 3,6 BIS[(5 PIPERIDIN 1 YLPENTYL)OXY] 9H XANTHEN 9 ONE; 3,6 BIS(3 BROMOBUTOXY) 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS(3 BROMOPENTOXY) 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS(3 BROMOPROPOXY) 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[3 (DIETHYLAMINO)PROPOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[3 (DIMETHYLAMINO)PROPOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[3 (DIPROPYLAMINO)PROPOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[3 (TERT BUTYLAMINO)PROPOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[4 (DIETHYLAMINO)BUTOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[4 (DIMETHYLAMINO)BUTOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[4 (DIPROPYLAMINO)BUTOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[4 (TERT BUTYLAMINO)BUTOXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[[5 (DIETHYLAMINO)PENTYL]OXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[[5 (DIPROPYLAMINO)PENTYL]OXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 3,6 BIS[[5-(TERT BUTYLAMINO)PENTYL]OXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; 33,6 BIS[[5 (DIMETHYLAMINO)PENTYL]OXY] 1 HYDROXY 8 METHYL 9H XANTHEN 9 ONE; ANTIMYCOBACTERIAL AGENT; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMOMETRICS; CROSS RESISTANCE; DRUG CYTOTOXICITY; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; VERO CELL;

ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; VERO CELLS; XANTHONES;

EID: 84890252122     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411309070003     Document Type: Review

References (25)

1. Minovski, N.; Vračko, M.; Šolmajer, T. Quantitative structureactivity relationship study of antitubercular fluoroquinolones. Mol. Diversity, 2011, 15, 417-426.
2. Janin, Y.L. Antituberculosis drugs: Ten years of research. Bioorg. Med. Chem., 2007, 15, 2479 -2513.
3. Donald, P.R.; Diacon, A.H. The early bactericidal activity of antituberculosis drugs: a literature review. Tuberculosis, 2008, 88, S75-S83.
4. Nascimento, F.B.; Poelhsitz, G.V.; Pavan, F.R.; Sato, D.N.; Leite, C.Q.F.; Selistre-De-Araújo, H.S.; Ellena, J.; Castellano, E.E.; Deflon, V.M.; Batista, A.A. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the ''SpymMe2" ligand, SpymMe2 = 4,6-dimethyl-2- mercaptopyrimidine. J. Inorg. Biochem., 2008, 102, 1783-1789.
5. Senthilkumar, P.; Dinakaran, M.; Banerjee, D.; Devakaran, R.V.; Yogeeswari, P.; China, A.; Nagaraja, V.; Sriram, D. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7- (substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. Bioorg. Med. Chem., 2008, 16, 2558 -2569.
6. Muthukrishnan, M.; Mujahid, M.; Yogeeswari, P.; Sriram, D. Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of Mycobacterium tuberculosis. Tetrahedron Lett., 2011, 52, 2387-2389.
7. Shen, R.; Wang, P.; Tang, N. Cytotoxic activity and DNA-binding properties of xanthone derivatives. J. Fluoresc., 2010, 20, 1287-1297.
8. Woo, S.; Jung, J.; Lee, C.; Kwon, Y.; Na, Y. Synthesis of new xanthone analogs and their biological activity test - cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study. Bioorg. Med. Chem. Lett., 2007, 17, 1163-1166.
9. Pickert, M.; Schaper, K.J.; Frahm, A.W. Substituted xanthones as antimycobacterial agents, part 2: antimycobacterial activity. Arch. Pharm., 1998, 331, 193-197.
10. Isaka, M.; Jaturapat, A.; Rukseree, K.; Danwisetkanjana, K.; Tanticharoen, M.; Thebtaranonth, Y. Phomoxanthones A and B, novel xanthone dimmers from the endophytic fungus Phomopsis species. J. Nat. Prod., 2001, 64, 1015-1018.
11. Suksamrarn, S.; Suwannapoch, N.; Phakhodee, W.; Thanuhiranlert, J.; Ratananukul, P.; Chimnoi, N.; Suksamrarn, A. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem. Pharm. Bull., 2003, 51, 857-859.
12. Namdaung, U.; Aroonrerk, N.; Suksamrarn, S.; Danwisetkanjana, K.; Saenboonrueng, J.; Arjchomphu, W.; Suksamrarn, A. Bioactive constituents of the root bark of Artocarpus rigidus subsp. Rigidus. Chem. Pharm. Bull., 2006, 54, 1433-1436.
13. Szkaradek, N.; Stachura, K.; Waszkielewicz, A.M.; Cegla, M.; Szneler, E.; Marona, H. Synthesis and antimycobacterial assay of some xanthone derivatives. Acta Pol. Pharm., 2008, 65, 21-28.
14. Micheletti, A.C.; Beatriz, A.; Lima, D.P.; Honda, N.K.; Pessoa, C.O.; Moraes, M.O.; Lotufo, L.V.; Magalhães, H.I.F.; Carvalho, N.C.P. Constituintes químicos de Parmotrema lichexanthonicum Eliasaro & Adler - isolamento, modificações estruturais e avaliaç ão das atividades antibiótica e citotóxica. Quim. Nova, 2009, 32, 12-20.
15. Micheletti, A.C.; Honda, N.K.; Lima, D.P.; Beatriz, A.; Sant'ana, M.R.; Carvalho, N.C.P.; Matos, M.F.C.; Queiróz, L.M.M.; Bogo, D.; Zorzatto, J.R. Chemical modifications of a natural xanthone and antimicrobial activity against multidrug resitant Staphylococcus aureus and cytotoxicity against human tumor cell lines. Quim. Nova, 2011, 34, 1014-1029.
16. Castanheiro, R.A.P.; Pinto, M.M.M.; Silva, A.M.S.; Cravo, S.M.M.; Gales, L.; Damas, A.M.; Nazareth, N.; Nascimento, M.S.J.; Eaton, G. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selctivity for MCF-7. Bioog. Med. Chem., 2007, 15, 6080-6088.
17. Palomino, J.; Martin, A.; Camacho, M.; Guerra, H.; Swings, J.; Portaels, F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistence in Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 2002, 46, 2720 -2722.
18. Collins, L.A.; Franzblau, S.G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother., 1997, 41, 1004-1009.
19. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; Mcmahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-1112.
20. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Groodich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human cell lines. J. Natl. Cancer Inst., 1991, 83, 757-766.
21. Orme, I.; Secrist, J.; Anathan, S.; Kwong, C.; Maddry, J.; Reynolds, R.; Poffenberger, A.; Michael, M.; Miller, L.; Krahenbuh, J.; Adams, L.; Biswas, A.; Franzblau, S.; Rouse, D.; Winfield, D.; J. Brooks. Search for new drugs for treatment of tuberculosis. Antimicrob. Agents Chemother., 2001, 45, 1943-1946.
22. Honda, N.K.; Pavan, F.R.; Coelho, R.G.; de Andrade Leite, S.R.; Micheletti, A.C.; Lopes, T.I.B.; Misutsu, M.Y.; Beatriz, A.; Brum, R.L.; Leite, C.Q.F. Antimycobacterial activity of lichen substances. Phytomedicine, 2010, 17, 328-332.
23. Pavan, F.R.; Maia, P.I.S.; Leite, S.R.A.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q.F. Thiosemicarbazones, semicarbazones, dithiocarbazatos and hydrazide/ hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur. J. Med. Chem., 2010, 45, 1898-1905.
24. Bailey, N.J.C.; Wang, Y.; Sampson, J.; Davis, W.; Whitcombe, I.; Hylands, P.J.; Croft, S.L.; Holmes, E. Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometrics. J. Pharm. Biomed. Anal., 2004, 35, 117-126.
25. Miyata, M.; Pavan, F.R.; Sato, D.N.; Marino, L.B.; Hirata, M.H.; Cardoso, R.F.; Melo, F.A.F.; Zanelli, C.F.; Leite. C.Q.F. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods. Biomed. Pharmacother., 2011, 65, 456-459.